{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T08:50:43Z","timestamp":1773391843627,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["COMPETE, POCI-01-0145-FEDER-007440, FCT. UID\/NEU\/04539\/2013- 2020"],"award-info":[{"award-number":["COMPETE, POCI-01-0145-FEDER-007440, FCT. UID\/NEU\/04539\/2013- 2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["MEDPERSYST, POCI-01-0145-FEDER-016428, BIGDATIMAGE, CENTRO-01-0145-FEDER-000016 Centro 2020 FEDER, COMPETE;"],"award-info":[{"award-number":["MEDPERSYST, POCI-01-0145-FEDER-016428, BIGDATIMAGE, CENTRO-01-0145-FEDER-000016 Centro 2020 FEDER, COMPETE;"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007472","name":"Funda\u00e7\u00e3o Luso-Americana para o Desenvolvimento","doi-asserted-by":"publisher","award":["FLAD Life Sciences Ed 2 2016"],"award-info":[{"award-number":["FLAD Life Sciences Ed 2 2016"]}],"id":[{"id":"10.13039\/501100007472","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Molecular Autism"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13229-017-0166-4","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T09:42:54Z","timestamp":1505814174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Testing the excitation\/inhibition imbalance hypothesis in a mouse model of the autism spectrum disorder: in vivo neurospectroscopy and molecular evidence for regional phenotypes"],"prefix":"10.1186","volume":"8","author":[{"given":"Joana","family":"Gon\u00e7alves","sequence":"first","affiliation":[]},{"given":"In\u00eas R.","family":"Violante","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Sereno","sequence":"additional","affiliation":[]},{"given":"Ricardo A.","family":"Leit\u00e3o","sequence":"additional","affiliation":[]},{"given":"Ying","family":"Cai","sequence":"additional","affiliation":[]},{"given":"Antero","family":"Abrunhosa","sequence":"additional","affiliation":[]},{"given":"Ana Paula","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Alcino J.","family":"Silva","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4364-6373","authenticated-orcid":false,"given":"Miguel","family":"Castelo-Branco","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,9,19]]},"reference":[{"key":"166_CR1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.biopsych.2017.03.005","volume":"81","author":"JH Foss-Feig","year":"2017","unstructured":"Foss-Feig JH, Adkinson BD, Ji JL, Yang G, Srihari VH, McPartland JC, Krystal JH, Murray JD, Anticevic A. Searching for cross-diagnostic convergence: neural mechanisms governing excitation and inhibition balance in schizophrenia and autism spectrum disorders. Biol Psychiatry. 2017;81:848\u201361.","journal-title":"Biol Psychiatry"},{"key":"166_CR2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fpsyt.2017.00069","volume":"8","author":"R Canitano","year":"2017","unstructured":"Canitano R, Pallagrosi M. Autism Spectrum Disorders and Schizophrenia Spectrum Disorders: Excitation\/Inhibition Imbalance and Developmental Trajectories. Front Psychiatry. 2017;8:69.","journal-title":"Front Psychiatry"},{"key":"166_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/GIM.0b013e3181bf15e3","volume":"12","author":"K Jett","year":"2010","unstructured":"Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genet Med. 2010;12:1\u201311.","journal-title":"Genet Med"},{"key":"166_CR4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11910-003-0064-3","volume":"3","author":"TL Rosser","year":"2003","unstructured":"Rosser TL, Packer RJ. Neurocognitive dysfunction in children with neurofibromatosis type 1. Curr Neurol Neurosci Rep. 2003;3:129\u201336.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"166_CR5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/1096-8628(200022)97:2<119::AID-AJMG3>3.0.CO;2-3","volume":"97","author":"K North","year":"2000","unstructured":"North K. Neurofibromatosis type 1. Am J Med Genet. 2000;97:119\u201327.","journal-title":"Am J Med Genet"},{"key":"166_CR6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s11689-016-9159-4","volume":"8","author":"S Garg","year":"2016","unstructured":"Garg S, Heuvelman H, Huson S, Tobin H, Green J. Northern UKNFRN: sex bias in autism spectrum disorder in neurofibromatosis type 1. J Neurodev Disord. 2016;8:26.","journal-title":"J Neurodev Disord"},{"key":"166_CR7","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s10803-014-2321-5","volume":"45","author":"S Garg","year":"2015","unstructured":"Garg S, Plasschaert E, Descheemaeker MJ, Huson S, Borghgraef M, Vogels A, Evans DG, Legius E, Green J. Autism spectrum disorder profile in neurofibromatosis type I. J Autism Dev Disord. 2015;45:1649\u201357.","journal-title":"J Autism Dev Disord"},{"key":"166_CR8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature711","volume":"415","author":"RM Costa","year":"2002","unstructured":"Costa RM, Federov NB, Kogan JH, Murphy GG, Stern J, Ohno M, Kucherlapati R, Jacks T, Silva AJ. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature. 2002;415:526\u201330.","journal-title":"Nature"},{"key":"166_CR9","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2008.09.060","volume":"135","author":"Y Cui","year":"2008","unstructured":"Cui Y, Costa RM, Murphy GG, Elgersma Y, Zhu Y, Gutmann DH, Parada LF, Mody I, Silva AJ. Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell. 2008;135:549\u201360.","journal-title":"Cell"},{"key":"166_CR10","doi-asserted-by":"crossref","first-page":"13141","DOI":"10.1073\/pnas.1004829107","volume":"107","author":"C Shilyansky","year":"2010","unstructured":"Shilyansky C, Karlsgodt KH, Cummings DM, Sidiropoulou K, Hardt M, James AS, Ehninger D, Bearden CE, Poirazi P, Jentsch JD, et al. Neurofibromin regulates corticostriatal inhibitory networks during working memory performance. Proc Natl Acad Sci U S A. 2010;107:13141\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"166_CR11","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/nn.3822","volume":"17","author":"AI Molosh","year":"2014","unstructured":"Molosh AI, Johnson PL, Spence JP, Arendt D, Federici LM, Bernabe C, Janasik SP, Segu ZM, Khanna R, Goswami C, et al. Social learning and amygdala disruptions in Nf1 mice are rescued by blocking p21-activated kinase. Nat Neurosci. 2014;17:1583\u201390.","journal-title":"Nat Neurosci"},{"key":"166_CR12","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/mp.2015.48","volume":"20","author":"A Omrani","year":"2015","unstructured":"Omrani A, van der Vaart T, Mientjes E, van Woerden GM, Hojjati MR, Li KW, Gutmann DH, Levelt CN, Smit AB, Silva AJ, et al. HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1. Mol Psychiatry. 2015;20:1311\u201321.","journal-title":"Mol Psychiatry"},{"key":"166_CR13","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cortex.2014.10.019","volume":"64","author":"MJ Ribeiro","year":"2015","unstructured":"Ribeiro MJ, Violante IR, Bernardino I, Edden RA, Castelo-Branco M. Abnormal relationship between GABA, neurophysiology and impulsive behavior in neurofibromatosis type 1. Cortex. 2015;64:194\u2013208.","journal-title":"Cortex"},{"key":"166_CR14","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/brain\/aws368","volume":"136","author":"IR Violante","year":"2013","unstructured":"Violante IR, Ribeiro MJ, Edden RA, Guimaraes P, Bernardino I, Rebola J, Cunha G, Silva E, Castelo-Branco M. GABA deficit in the visual cortex of patients with neurofibromatosis type 1: genotype-phenotype correlations and functional impact. Brain. 2013;136:918\u201325.","journal-title":"Brain"},{"key":"166_CR15","doi-asserted-by":"publisher","unstructured":"Violante IR, Patricio M, Bernardino I, Rebola J, Abrunhosa AJ, Ferreira N, Castelo-Branco M. GABA deficiency in NF1: A multimodal [11C]-flumazenil and spectroscopy study. Neurology. 2016;87(9):897-04. doi: \n10.1212\/WNL.0000000000003044\n\n.","DOI":"10.1212\/WNL.0000000000003044"},{"key":"166_CR16","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1212\/WNL.0000000000003044","volume":"87","author":"IR Violante","year":"2016","unstructured":"Violante IR, Patricio M, Bernardino I, Rebola J, Abrunhosa AJ, Ferreira N, Castelo-Branco M. GABA deficiency in NF1: a multimodal [11C]-flumazenil and spectroscopy study. Neurology. 2016;87:897\u2013904.","journal-title":"Neurology"},{"key":"166_CR17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/ng0397-281","volume":"15","author":"AJ Silva","year":"1997","unstructured":"Silva AJ, Frankland PW, Marowitz Z, Friedman E, Laszlo GS, Cioffi D, Jacks T, Bourtchuladze R. A mouse model for the learning and memory deficits associated with neurofibromatosis type I. Nat Genet. 1997;15:281\u20134.","journal-title":"Nat Genet"},{"key":"166_CR18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/86898","volume":"27","author":"RM Costa","year":"2001","unstructured":"Costa RM, Yang T, Huynh DP, Pulst SM, Viskochil DH, Silva AJ, Brannan CI. Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1. Nat Genet. 2001;27:399\u2013405.","journal-title":"Nat Genet"},{"key":"166_CR19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1749-6632.1987.tb32915.x","volume":"508","author":"PA Bottomley","year":"1987","unstructured":"Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci. 1987;508:333\u201348.","journal-title":"Ann N Y Acad Sci"},{"key":"166_CR20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G","volume":"41","author":"I Tkac","year":"1999","unstructured":"Tkac I, Starcuk Z, Choi IY, Gruetter R. In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med. 1999;41:649\u201356.","journal-title":"Magn Reson Med"},{"key":"166_CR21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/nbm.698","volume":"14","author":"SW Provencher","year":"2001","unstructured":"Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 2001;14:260\u20134.","journal-title":"NMR Biomed"},{"key":"166_CR22","doi-asserted-by":"publisher","unstructured":"Masi A, DeMayo MM, Glozier N, Guastella AJ. An overview of autism spectrum disorder, heterogeneity and treatment options. Neurosci Bull. 2017;33(2):183-93. doi:\n10.1007\/s12264-017-0100-y\n\n.","DOI":"10.1007\/s12264-017-0100-y"},{"key":"166_CR23","doi-asserted-by":"publisher","unstructured":"Lee E, Lee J, Kim E. Excitation\/inhibition imbalance in animal models of autism spectrum disorders. Biol Psychiatry. 2017;81(10):838-847. doi:\n10.1016\/j.biopsych.2016.05.011\n\n.","DOI":"10.1016\/j.biopsych.2016.05.011"},{"key":"166_CR24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1866-1955-5-3","volume":"5","author":"IR Violante","year":"2013","unstructured":"Violante IR, Ribeiro MJ, Silva ED, Castelo-Branco M. Gyrification, cortical and subcortical morphometry in neurofibromatosis type 1: an uneven profile of developmental abnormalities. J Neurodev Disord. 2013;5:3.","journal-title":"J Neurodev Disord"},{"key":"166_CR25","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1471-4159.2005.03169.x","volume":"94","author":"A Bauer","year":"2005","unstructured":"Bauer A, Zilles K, Matusch A, Holzmann C, Riess O, von Horsten S. Regional and subtype selective changes of neurotransmitter receptor density in a rat transgenic for the Huntington\u2019s disease mutation. J Neurochem. 2005;94:639\u201350.","journal-title":"J Neurochem"},{"key":"166_CR26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00213-013-3080-2","volume":"229","author":"K Muneoka","year":"2013","unstructured":"Muneoka K, Shirayama Y, Horio M, Iyo M, Hashimoto K. Differential levels of brain amino acids in rat models presenting learned helplessness or non-learned helplessness. Psychopharmacology. 2013;229:63\u201371.","journal-title":"Psychopharmacology"},{"key":"166_CR27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fncel.2014.00119","volume":"8","author":"G Deidda","year":"2014","unstructured":"Deidda G, Bozarth IF, Cancedda L. Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives. Front Cell Neurosci. 2014;8:119.","journal-title":"Front Cell Neurosci"},{"key":"166_CR28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1570159052773396","volume":"3","author":"DW Volk","year":"2005","unstructured":"Volk DW, Lewis DA. GABA targets for the treatment of cognitive dysfunction in schizophrenia. Curr Neuropharmacol. 2005;3:45\u201362.","journal-title":"Curr Neuropharmacol"},{"key":"166_CR29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1212\/WNL.0b013e3181b163a5","volume":"73","author":"PL Pearl","year":"2009","unstructured":"Pearl PL, Gibson KM, Quezado Z, Dustin I, Taylor J, Trzcinski S, Schreiber J, Forester K, Reeves-Tyer P, Liew C, et al. Decreased GABA-A binding on FMZ-PET in succinic semialdehyde dehydrogenase deficiency. Neurology. 2009;73:423\u20139.","journal-title":"Neurology"}],"container-title":["Molecular Autism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13229-017-0166-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T09:43:00Z","timestamp":1505814180000},"score":1,"resource":{"primary":{"URL":"http:\/\/molecularautism.biomedcentral.com\/articles\/10.1186\/s13229-017-0166-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,19]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["166"],"URL":"https:\/\/doi.org\/10.1186\/s13229-017-0166-4","relation":{},"ISSN":["2040-2392"],"issn-type":[{"value":"2040-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,19]]},"article-number":"47"}}